Skip to content
Disclosery

EXANE DERIVATIVES: FCX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FCX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,337 FCX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,337 shares
    Change vs previous 13F -38,521 shares

    0.06% of the 13F portfolio, value $97,630.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 41,858 shares
    Change vs previous 13F -38,726 shares

    0.59% of the 13F portfolio, value $2,082,031.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 80,584 shares
    Change vs previous 13F +19,152 shares

    0.82% of the 13F portfolio, value $3,362,879.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 61,432 shares
    Change vs previous 13F +17,693 shares

    0.5% of the 13F portfolio, value $1,998,462.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 43,739 shares
    Change vs previous 13F -50,041 shares

    0.37% of the 13F portfolio, value $1,562,829.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 93,780 shares
    Change vs previous 13F +48,229 shares

    0.93% of the 13F portfolio, value $3,088,318.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 45,551 shares
    Change vs previous 13F +37,795 shares

    0.36% of the 13F portfolio, value $1,185,289.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 7,756 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $121,307.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).